HAND GESTURES FOR ANIMATING AND CONTROLLING VIRTUAL AND GRAPHICAL ELEMENTS

A system has been developed to control virtual elements on a screen using hand gestures captured by a camera in eyewear. The system detects hand shapes and matches them to predefined gestures stored in a library, triggering actions accordingly. For example, making an opening gesture causes graphical elements to move away from a menu icon, while a closing gesture makes them retreat back towards it.

MOBILE DEVICE DISPLAYING REAL TIME SPORTS STATISTICS

A mobile device can show live sports stats using a memory and processor. The device gets real-time stats from an outside source and needs to be authenticated. It's a handy tool for keeping up with sports on the go.

CORONA VIRUS-SPECIFIC T CELL RECEPTOR FUSION CONSTRUCTS, VECTORS ENCODING THE SAME, T CELLS COMPRISING THE SAME AND USES THEREOF

A new invention involves a T cell receptor fusion construct that combines specific parts to target the spike protein of coronaviruses, including SARS-CoV-2 and SARS-CoV-1, and ACE2. This construct can be encoded in a vector for modifying T cells to enhance their ability to fight diseases caused by coronaviruses like COVID-19 and SARS. The invention aims to use these modified T cells in treatments for coronavirus-related illnesses.

Augmented reality object management system

An augmented reality system has been created to manage virtual objects in a digital scene. The system uses networking nodes to analyze the scene and adjust the presence of virtual objects based on interference among elements. This interference can either enhance or suppress the appearance of virtual objects in the augmented reality experience.

CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE

Chimeric antigen receptors (CARs) are used to target tumor cells that have a specific protein called glypican-3 (GPC3). These CAR-based immunotherapeutic compositions are designed to treat and prevent cancer by attacking the tumor cells. This invention focuses on using CAR technology to fight cancer more effectively.

FUSION PROTEIN, AND PREPARATION METHOD AND USE THEREOF

A fusion protein has been developed for targeting and degrading KRas proteins in cancer cells, using a combination of specific peptides. This innovative approach allows the fusion protein to target both wild-type and mutant-type KRas proteins simultaneously, enhancing the effectiveness of anti-cancer drugs. By improving drug sensitivity in KRas mutant-type tumors, this technology offers a promising new strategy for cancer treatment.

BIOINTEGRATIVE IMPLANTABLE CELL ENCAPSULATION DEVICE AND SYSTEM

The device is used to implant cells into a person's body without causing an immune response. It can carry cells that produce helpful substances for the body. This helps in treating various health issues by delivering therapeutic molecules to the affected areas.

Wearable computing apparatus for augmented reality, virtual reality and artificial intelligence interactions, and methods relating thereto

A wearable device worn on the hand that combines augmented reality, virtual reality, and artificial intelligence features. It has processors, memory, haptic motors, and sensors to track hand movements. Additionally, it includes a detachable component with sensors and motors on each finger to enhance interaction capabilities.

Cancer immunotherapy using virus particles

A new way to treat cancer involves giving a patient a virus or virus-like particle directly into the tumor. This method helps the body's immune system fight against the cancer cells. By using these virus particles, doctors can target and destroy cancer cells more effectively.

METHODS USING ANTI-SLC3A2 AUTOANTIBODIES AND SLC3A2 FOR DETECTION OF GLIOMA BRAIN TUMOR FROM PATIENT SERUM

These methods help doctors detect brain tumors early by using patient blood samples. They can specifically identify Glioblastoma brain tumors with high accuracy using a certain type of antibody called anti-SLC3a2. This new approach improves the chances of successful treatment for patients with advanced stage brain tumors.